Loss of heterozygosity at chromosome arm 13q and RB1 status in human prostate cancer
✍ Scribed by Alain Latil; Ivan Bièche; Sandrine Pesche; Alain Volant; Antoine Valèri; Georges Fournier; Olivier Cussenot; Rosette Lidereau
- Book ID
- 117253666
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 847 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1532-8392
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Loss of heterozygosity (LOH) was examined at 27 loci on chromosomes 3p, 6q, I Ip, 13q. 17 and X in 42 human ovarian tumors. LOH was detected in I 2 of 26 (46%) and 5 of I 2 (42%) informative cases at 2 chromosome 13q loci, D13S32 and D I3534 respectively. On chromosome Xp, tumor-specific allele loss
Forty-four breast carcinomas were studied for loss of heterozygosity (LOH) at 25 microsatellite markers distributed almost evenly along chromosome arm 22q. LOH at at least one marker were observed in 66% tumors, while 6 regions of consistent LOH were identified. The size of each region ranged betwee
The tumor suppressor gene BRCA1 on chromosome 17q21 has been characterized and shown to be mutated in patients with familial breast and ovarian cancer. Several studies examined the relatives of women with breast cancer and noted an association with ovarian and prostate cancer. This study investigate